Dexamethasone palmitate nanoparticles are promising in the treatment of inflammation in rheumatoid arthritis with a very significant difference occurring at the late stage of inflammation allowing to prevent the progression of the disease. It is grouped under the following drug class(es): Corticosteroids and Systemic corticosteroids. Its therapeutic use is listed as anti-inflammatories and antirheumatic agents. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Dexamethasone 21-palmitate and Limethason. Its PubChem CID is 63044.
Dexamethasone palmitate
| CAS No | 14899-36-6 |
|---|---|
| Molecular Formula | C38H59FO6 |
| Molecular Weight | 630.9 g/mol |
| Synonyms | [2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] hexadecanoate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Dexamethasone palmitate nanoparticles are promising in the treatment of inflammation in rheumatoid arthritis with a very significant difference occurring at the late stage of inflammation allowing to prevent the progression of the disease.
The listed CAS number is 14899-36-6.
The listed molecular formula is C38H59FO6.
The listed molecular weight is 630.9 g/mol.
[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] hexadecanoate.
The source lists Dexamethasone 21-palmitate and Limethason.